(Q45001444)

8 December 2017

Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population (English)

1 reference

8 December 2017

visceral leishmaniasis

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Daniel M Avelar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Miriam C de Souza Testasicca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Mariana Silva dos Santos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Leopoldo Marques Machado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Angela Vieira Serufo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Daniel Doro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ana Maria Leonardi Tibúrcio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Christiane de Freitas Abrantes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

George Luiz Lins Machado-Coelho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Gabriel Grimaldi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ana Paula Fernandes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

2 May 2014

1 reference

8 December 2017

Veterinary Parasitology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

169-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

Leishmaniasis worldwide and global estimates of its incidence

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Cytokine profiles in canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Leishmaniases of the New World: current concepts and implications for future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

The Brazilian Leishmaniasis Control Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune®

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Control of visceral leishmaniasis in latin america-a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Regulations and procedures in parasite vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Seroepidemiology of the human polyomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

TaqMan-based detection of Leishmania infantum DNA using canine samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2014.04.025

10.1016/J.VETPAR.2014.04.025

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24863572%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference